Skip to main content
Caplight Logo









Pathware

Pathware

Private
Golden, ColoradoHealthcare & Life Scienceshttps://www.pathware.com/

Last Round

Series A

Apr 19, 2022

Total Funding Raised

$8.46M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Pathware is a medical technology company that has developed a digital pathology platform intended for point-of-care diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI

Business Model

B2B

Customer Profile

Hardware + Subscription, Revenue Share

AI Layer

Application

Keywords

digital pathologypoint-of-care diagnosticsbiopsy quality assessmentcomputational microscopyrapid onsite evaluationROSEmedical imaging AIpathology AIAI pathologywhole-slide imagingfine-needle aspirationclinical workflow automationmedtechbiopsy managementdiagnostic imaging

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pathware Comparables

Compare Pathware with similar companies based on industry and business-model similarity.

Pathware comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Instapath Inc.
84%
OptraSCAN
78%
Techcyte, Inc.
76%

Pathware Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 19, 2022
SeedSep 9, 2019

Key People

Founding team and executive leadership

TJ Meyer

Chief Executive Officer

Executive Team

Troy Holsing

Chief Technology Officer

Executive Team

Pathware Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 23, 2026

    Grew 25% QoQ, from 12 to 15 employees.

  • Apr 19, 2022

    $7M round led by UnityPoint Health Ventures and Level Eight Ventures.

Pathware Filings

Explore SEC and related filing metadata, where available.

Pathware filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Pathware's valuation, stock price, and market status.

Is Pathware a public or private company?

Pathware is a private company.

What is the current stock price of Pathware?

Pathware is a private company with no public stock price. No recent secondary market data is available.

How much is Pathware worth (valuation)?

Valuation information for Pathware is not publicly available.

Can I buy Pathware stock?

Pathware shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Pathware's last funding round?

Pathware's most recent funding round was Series A on April 19, 2022.

Who are the main investors in Pathware?

Key investors in Pathware include UnityPoint Health Ventures, Level Eight Ventures, National Science Foundation.

Will Pathware IPO soon?

No public IPO plans have been announced for Pathware.

How can I track Pathware secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pathware's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGolden, Colorado
Employee Range12
Year Founded2017
Last FundingApr 19, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?